In vivo brain microdialysis as a formulation-screening tool for a poorly soluble centrally acting drug

References

• Alsenz J, Kansy M. High throughput solubility measurement in drug discovery and development. Adv Drug Deliv Rev 2007;59:546–67
   PubMed Web of Science ®Google Scholar
• Bertilsson L. Clinical pharmacokinetics of carbamazepine. Clinical Pharmacokinet 1978;3:128–43
   PubMed Web of Science ®Google Scholar
• Shan N, Zaworotko MJ. The role of cocrystals in pharmaceutical science. Drug Discov Today 2008;13:440–6
   PubMed Web of Science ®Google Scholar
• Yan Z, Xu W, Sun J, et al. Characterization and in vivo evaluation of an inclusion complex of oridonin and 2-hydroxypropyl-β-cyclodextrin. Drug Dev Ind Pharm 2008;34:632–41
   PubMed Web of Science ®Google Scholar
• Phillip Lee YH, Sathigari S, Jean Lin YJ, et al. Gefitinib--cyclodextrin inclusion complexes: physico-chemical chemicalaracterization and dissolution studies. Drug Dev Ind Pharm 2009;35:1113–20
   PubMed Web of Science ®Google Scholar
• Wang S, Ding Y, Yao Y. Inclusion complexes of fluorofenidone with β-cyclodextrin and hydroxypropyl-β-cyclodextrin. Drug Dev Ind Pharm 2009;35:808–13
   PubMed Web of Science ®Google Scholar
• Brewster ME, Loftsson T. Cyclodextrins as pharmaceutical solubilizers. Drug solubility: how to measure it, how to improve it. Adv Drug Deliv Rev 2007;59:645–66
   PubMed Web of Science ®Google Scholar
• Blagden N, de Matas M, Gavan PT, York P. Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates. Drug solubility: how to measure it, how to improve it. Adv Drug Deliv Rev 2007;59:617–30
   PubMed Web of Science ®Google Scholar
• El-Zein H, Riad L, El-Bary AA. Enhancement of carbamazepine dissolution: in vitro and in vivo evaluation. Int J Pharm 1998;168:209–20
   Web of Science ®Google Scholar
• Bradbury MW. The blood-brain barrier. Exp Physiol 1993;78:453–72
   PubMed Web of Science ®Google Scholar
• McKinney DL, Gogova M, Davies BD, et al. Evaluation of the effect of ammonia on nicotine pharmacokinetics using rapid arterial sampling. Nicotine Tob Res 2012;14:586–95
   PubMed Web of Science ®Google Scholar
• Song P, Mabrouk OS, Hershey ND, Kennedy RT. In vivo neurochemical monitoring using benzoyl chloride derivatization and liquid chromatography–mass spectrometry. Anal Chem 2012;84:412–19
   PubMed Web of Science ®Google Scholar
• Wang T, Oberoi RK, Elmquist WF. Determination of cediranib in mouse plasma and brain tissue using high-performance liquid chromatography-mass spectrometry. J Chromatogr B: Analyt Technol Biomed Life Sci 2011;879:3812–7
   PubMed Web of Science ®Google Scholar
• Clinckers R, Smolders I, Meurs A, et al. Hippocampal dopamine and serotonin elevations as pharmacodynamic markers for the anticonvulsant efficacy of oxcarbazepine and 10,11-dihydro-10-hydroxycarbamazepine. Neurosci Lett 2005;390:48–53
   PubMed Web of Science ®Google Scholar
• Okada M, Hirano T, Mizuno K, et al. Biphasic effects of carbamazepine on the dopaminergic system in rat striatum and hippocampus. Epilepsy Res 1997;28:143–53
   PubMed Web of Science ®Google Scholar
• Patterson JE, James MB, Forster AH, Rades T. Melt extrusion and spray drying of carbamazepine and dipyridamole with polyvinylpyrrolidone/vinyl acetate copolymers. Drug Dev Ind Pharm 2008;34:95–106
   PubMed Web of Science ®Google Scholar
• Liu H-J, Li P, Wei Q. Magnetic N-succinyl chitosan/alginate beads for carbamazepine delivery. Drug Dev Ind Pharm 2010;36:1286–94
   PubMed Web of Science ®Google Scholar
• Zugasti ME, Zornoza A, Goni Mdel M, et al. Influence of soluble and insoluble cyclodextrin polymers on drug release from hydroxypropyl methylcellulose tablets. Drug Dev Ind Pharm 2009;35:1264–70
   PubMed Web of Science ®Google Scholar
• Tayel SA, Soliman II, Louis D. Improvement of dissolution properties of carbamazepine through application of the liquisolid tablet technique. Eur J Pharm Biopharm 2008;69:342–7
   PubMed Web of Science ®Google Scholar
• Koester LS, Bertuol JB, Groch KR, et al. Bioavailability of carbamazepine:β-cyclodextrin complex in beagle dogs from hydroxypropylmethylcellulose matrix tablets. Eur J Pharm Sci 2004;22:201–7
   PubMed Web of Science ®Google Scholar
• Shikhar A, Bommana MM, Gupta SS, Squillante E. Formulation development of carbamazepine-nicotinamide co-crystals complexed with [gamma]-cyclodextrin using supercritical fluid process. J Supercrit Fluids 2011;55:1070–8
   Web of Science ®Google Scholar
• Sethia S, Squillante E. Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods. Int J Pharm 2004;272:1–10
   PubMed Web of Science ®Google Scholar
• Ahmad S, Fowler LJ, Whitton PS. Lamotrigine, carbamazepine and phenytoin differentially alter extracellular levels of 5-hydroxytryptamine, dopamine and amino acids. Epilepsy Res 2005;63:141–9
   PubMed Web of Science ®Google Scholar
• Clinckers R, Smolders I, Meurs A, et al. Anticonvulsant action of hippocampal dopamine and serotonin is independently mediated by D2 and 5-HT receptors. J Neurochem 2004;89:834–43
   PubMed Web of Science ®Google Scholar
• Okada M, Hirano T, Mizuno K, et al. Effects of carbamazepine on hippocampal serotonergic system. Epilepsy Res 1998;31:187–98
   PubMed Web of Science ®Google Scholar
• Smolders I, Clinckers R, Meurs A, et al. Direct enhancement of hippocampal dopamine or serotonin levels as a pharmacodynamic measure of combined antidepressant–anticonvulsant action. Neuropharmacology 2008;54:1017–28
   PubMed Web of Science ®Google Scholar
• Cocero MJ, Martín A, Mattea F, Varona S. Encapsulation and co-precipitation processes with supercritical fluids: fundamentals and applications. J Supercrit Fluids 2009;47:546–55
   Web of Science ®Google Scholar
• Bandi N, Wei W, Roberts CB, et al. Preparation of budesonide-- and indomethacin--hydroxypropyl-β-cyclodextrin (HPBCD) complexes using a single-step, organic-solvent-free supercritical fluid process. Eur J Pharm Sci 2004;23:159–68
   PubMed Web of Science ®Google Scholar
• Paxinos G, Watson C. The rat brain in stereotaxic coordinates. Sydney; Orlando (FL): Academic Press; 1986
   Google Scholar
• Shimoyama M, Tanigawa Y, Ito T, et al. Nicotinamide deamidation by microorganisms in rat stomach. J Bacteriol 1971;108:191–5
   PubMed Web of Science ®Google Scholar
• Tanigawa Y, Shimoyama M, Murashima R, et al. The role of microorganisms as a function of nicotinamide deamidation in rat stomach. Biochim Biophys Acta 1970;201:394–7
   PubMed Web of Science ®Google Scholar
• Remenar JF, Morissette SL, Peterson ML, et al. Crystal engineering of novel cocrystals of a triazole drug with 1,4-dicarboxylic acids. J Am Chem Soc 2003;125:8456–7
   PubMed Web of Science ®Google Scholar